Colorectal signet ring cell carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who obtain informed consent prior to implementing any trial-related procedures 2. Aged 18 to 75 3. Have clinically and pathologically confirmed primary colorectal indolent cell carcinoma (=50% indolent cell component) 4. Complete clinicopathological data available. 5. The availability of sufficient histological specimens for testing
Exclusion criteria
Exclusion criteria: 1. Diagnosed with a cancer other than colorectal cancer within 5 years 2. Have a medical history or evidence of disease that may interfere with the results of the trial, prevent the subject from participating in the study in its entirety, have abnormal treatment or laboratory test results, or have other conditions that, in the investigator's opinion, make the subject unsuitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mutation landscape; | — |
Secondary
| Measure | Time frame |
|---|---|
| tumor immune microenvironment;mIHC; | — |
Countries
China
Contacts
Shanxi Provincial Cancer Hospital